 |
Articles: Drug/Product Approvals |
Prior Articles
Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review Designation for Rifaximin NDA for the Maintenance of Remission of Hepatic Encephalopathy
Salix Pharmaceuticals, 08/25/09
Free full text
Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 08/24/09
Free full text
Warner Chilcott Completes Irish Redomestication
Warner Chilcott, 08/24/09 Merck is Pleased the FDA and CDC Re-affirm the Safety Profile of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]
Merck & Co., 08/21/09
Free full text
Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement
Bristol Myers-Squibb Company, 08/21/09
Free full text
Dey Issues Advisory
Mylan, 08/21/09 Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS)
Neuropsychopharmacology, 08/20/09 Merck Wins SINGULAIR Patent Infringement Lawsuit
Merck & Co., 08/20/09
Free full text
Fda accepts drug application for miconazole lauriad to treat oropharyngeal candidiasis
Par Pharmaceutical, 08/20/09 Par pharmaceutical and aveva drug delivery systems receive final approval to market generic catapres tts
Par Pharmaceutical, 08/19/09 CryoLife Announces Implants of First FDA-Cleared SynerGraft Processed Human Cardiac Patch Material
Cryolife, 08/19/09
Free full text
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla HIV Treatment
Mylan, 08/19/09 Gen-Probe Begins U.S. Clinical Study of APTIMA Trichomonas Vaginalis Assay on the TIGRIS System
Gen-Probe, 08/18/09
Free full text
BTG Collaborator Onyx Gains Approval to Progress Oncology Compound into Clinical Development
BTG, 08/18/09
Free full text
US FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
Novartis, 08/18/09
Free full text
Onglyza (saxagliptin), a new treatment for type 2 diabetes mellitus in adults, now available in u.s. pharmacies
AstraZeneca, 08/17/09
Free full text
Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient
Daiichi Sankyo, 08/17/09
Free full text
Gilead Sciences Receives Subpoena from U.S. Department of Health and Human Services Regarding Ranexa
Gilead, 08/17/09
Free full text
Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 08/17/09
Free full text
Angiotech receives approval for quill srs pdo, monoderm,
polypropylene and nylon product lines for sale in brazil
Angiotech Pharmaceuticals, 08/14/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
